Source: http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=201320140AB604&search_keywords
Timestamp: 2019-12-09 13:57:51
Document Index: 558589309

Matched Legal Cases: ['art 1', 'art 1', 'art 1', 'art 2', 'art 1', 'art 1']

PDF2 PDF |Add To My Favorites | Version: 09/11/13 - Amended Senate 09/06/13 - Amended Senate 08/13/13 - Amended Senate 04/29/13 - Amended Assembly 02/20/13 - Introduced
AB604:v95#DOCUMENT
An act to amend Sections 2220.05, 2242, and 2264 of, and to add Chapter 18 (commencing with Section 26000) to Division 9 of, the Business and Professions Code, and to amend Section 11362.7 of, and to amend and repeal Section 11362.775 of, the Health and Safety Code, relating to medical cannabis, and making an appropriation therefor.
AB 604, as amended, Ammiano. Medical cannabis: state regulation and enforcement.
This act shall be known, and may be cited, as the Medical Cannabis Regulation and Control Act.
(1) In 1996, the people of the State of California enacted the Compassionate Use Act of 1996, codified in Section 11362.5 of the Health and Safety Code. The people of the State of California declared that their purpose in enacting the measure was, among other things, “to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the person’s health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.”
(2) The Compassionate Use Act of 1996 called on state government to implement a plan for the safe and affordable distribution of marijuana to all patients in medical need of marijuana.
(3) In 2003, the Legislature enacted the Medical Marijuana Program Act (MMPA), codified in Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code. Under the guidance of the MMPA, approximately 60 California cities and counties have created medical marijuana access ordinances that can act as a guide for the state. However, many other cities and counties are calling for more guidance and regulation from the state and have passed bans or moratoria on medical marijuana cultivation and distribution while awaiting this guidance.
(4) Greater certainty and uniformity are urgently needed regarding the rights and obligations of medical marijuana facilities, and for the imposition and enforcement of regulations to prevent unlawful cultivation and the diversion of marijuana to nonmedical use.
(5) Despite the passage of the Compassionate Use Act of 1996 and the MMPA, because of the lack of an effective statewide system for regulating and controlling medical marijuana, local law enforcement officials have been confronted with uncertainty about the legality of some medical marijuana cultivation and distribution activities. The current system of collectives and cooperatives makes law enforcement difficult and endangers patient safety because of an inability to monitor the supply of medical marijuana in the state and the lack of quality control, testing, and labeling requirements. As a result, many cities and counties have passed local ordinances that in some cases ban the cultivation or distribution of medical marijuana.
(6) For the protection of all Californians, the state must act to regulate and control medical marijuana and not preempt local government ordinances. Cities and counties should be allowed to impose reasonable local taxes and enact reasonable zoning regulations and other restrictions applicable to the cultivation and distribution of medical marijuana based on local needs. In order to provide patients with access to safe medical marijuana products, while at the same time preventing diversion of marijuana to nonmedical uses and protecting the public, it is necessary to amend the MMPA and to establish a comprehensive structure for regulating the cultivation, production, and distribution of medical marijuana products.
(7) A state entity shall be created to regulate and control the mandatory registration of all entities involved in the commercial cultivation, processing, manufacturing, testing, transportation, distribution, and sale of medical marijuana in this state. Patients and their primary caregivers shall continue to be allowed to cultivate medical marijuana for the personal medical purposes of the individual patient, but only medical marijuana produced in compliance with this act may be sold or commercially distributed.
(8) This act is not intended to prevent cities and counties from imposing reasonable local taxes and enacting reasonable zoning regulations and other restrictions applicable to the commercial cultivation and distribution of medical marijuana based on local needs.
(9) It is the intent of the Legislature that the state entity created to regulate and control medical marijuana solicit input from cities and counties that have local ordinances or regulations allowing for the registering, permitting, or licensing of medical marijuana businesses, dispensaries, or other entities involved in providing medical marijuana to patients in the process of promulgating standards and regulations pursuant to this act.
(10) It is the intent of the Legislature that entities provided immunity under Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013, ballot, shall be considered the equivalent of entities that are registered, permitted, or licensed as a medical marijuana business, dispensary, or other entity involved in providing medical marijuana to patients under a local ordinance and shall be considered in compliance with a local ordinance for the purposes of the implementation of this act and any regulations promulgated by the Department of Alcoholic Beverage Control.
(11) The provisions of this act are enacted pursuant to the powers reserved to the State of California and its people under the Tenth Amendment to the United States Constitution.
(12) Nothing in this act is intended to require any individual or entity to engage in any conduct that violates federal law or to exempt anyone from any requirement of federal law or to pose any obstacle to federal enforcement of federal law.
(b) It is therefore the intent of the Legislature, in enacting this act, to accomplish all of the following:
(1) To establish a statewide system for regulating and controlling commercial medical cannabis activities by creating a state entity to enact and enforce regulations governing the cultivation, processing, manufacturing, testing, transportation, distribution, and sale of commercial medical cannabis.
(2) To allow cities and counties to enact reasonable zoning regulations or other restrictions applicable to the cultivation, processing, manufacturing, testing, and distribution of commercial medical cannabis based on local needs.
(3) To establish the Division of Medical Cannabis Regulation and Enforcement to be located within the Department of Alcoholic Beverage Control to provide a governmental agency that will ensure the strict, honest, impartial, and uniform administration and enforcement of the medical cannabis laws throughout the state.
(4) To fulfill the promise of the Compassionate Use Act of 1996 to “implement a plan for the safe and affordable distribution of marijuana to all patients in medical need of marijuana.”
(5) To establish a statewide registration process for commercial medical cannabis activities to identify for law enforcement which entities are exempt from state criminal penalties.
(6) To reduce the cost of commercial medical cannabis enforcement by controlling commercial medical cannabis production and distribution through comprehensive statewide regulation and providing law enforcement guidelines to more easily determine whether or not a person is acting in conformance with the state’s medical cannabis laws.
(3) Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances, or recommending marijuana to patients for medical purposes, without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(a) Prescribing, dispensing, or furnishing dangerous drugs as defined in Section 4022, or recommending marijuana to a patient for medical purposes, without an appropriate prior examination and a medical indication, including an in-person examination when recommending marijuana, constitutes unprofessional conduct.
The employing, directly or indirectly, the aiding, or the abetting of any unlicensed person or any suspended, revoked, or unlicensed practitioner to engage in the practice of medicine, including employment by, or other agreement with, a mandatory commercial registrant acting pursuant to the Medical Cannabis Regulation and Control Act or a dispensary to provide recommendations for medical marijuana, or any other mode of treating the sick or afflicted which requires a license to practice constitutes unprofessional conduct.
Chapter 18 (commencing with Section 26000) is added to Division 9 of the Business and Professions Code, to read:
CHAPTER 18. Medical Cannabis Regulation
(a) It is the intent of the Legislature in enacting this chapter to provide for the comprehensive regulation of the commercial cultivation, manufacturing, testing, transportation, distribution, and sale of medical cannabis and the enforcement of laws relating to commercial medical cannabis activities.
(b) This chapter is an exercise of the police powers of the state for the protection of the safety, welfare, health, peace, and morals of the people of the state.
Subject to the authority of a city or county pursuant to Section 26010, the state shall have the exclusive right and power to regulate and register persons for the cultivation, manufacture, testing, transportation, storage, distribution, sale, purchase, and possession of medical cannabis within the state. In the exercise of these rights and powers, the Legislature shall not constitute the state or any of its agencies as a cultivator, manufacturer, transporter, tester, or seller of medical cannabis.
(a) “Cannabis” means all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin. It does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. “Cannabis” also means the separated resin, whether crude or purified, obtained from marijuana.
(b) “Department” means the Department of Alcoholic Beverage Control.
(c) “Dispensary” means a mandatory commercial registrant that dispenses cannabis or medical cannabis products through a retail storefront.
(d) “Division” means the Division of Medical Cannabis Regulation and Enforcement.
(e) “Fund” means the Medical Cannabis Regulation Fund established pursuant to Section 26028.
(f) “Identification program” means the universal identification certificate program for mandatory commercial registrants.
(g) “Mandatory commercial registrant” or “registrant” means any individual, partnership, joint venture, association, limited liability company, corporation, estate, trust, receiver, syndicate, or any other group or combination thereof acting as a unit to commercially cultivate, process, possess, store, manufacture, test, transport, distribute, or sell medical cannabis in compliance with this chapter, other than a patient or a patient’s primary caregiver, as defined by the Compassionate Use Act of 1996, growing, possessing, storing, manufacturing, transporting, or providing medical cannabis exclusively for the personal medical purposes of individual patients as defined in subdivision (b) of Section 26050.
(h) “Medical cannabis product” means any cannabis product, including concentrates and extractions, that is cultivated, processed, packaged, and distributed in full compliance with the requirements of this chapter and with any regulations adopted by the department pursuant to its rulemaking authority. “Medical cannabis product” includes medically infused products that contain medical cannabis and are intended for oral or topical consumption by a qualified patient.
(i) “Person” includes any individual, firm, copartnership, joint adventure venture, association, corporation, estate, trust, business trust, receiver, syndicate, or any other group or combination acting as a unit and includes the plural as well as the singular number.
(j) “Testing and labeling” means mandatory labeling and a quality assurance plan in place that addresses all of the following:
(1) Potency.
(2) Chemical residue.
(3) Microbiological contaminants.
(4) Random sample testing of medical cannabis and medical cannabis products.
(5) Handling, care, and storage.
(6) Date and location of production and manufacturing.
This chapter does not prevent a city or county from doing any of the following:
(a) Adopting local ordinances that ban or regulate the location, operation, or establishment of a cannabis dispensary mandatory commercial registrant.
(b) The civil or criminal enforcement of the ordinances described in subdivision (a).
(c) Establishing a reasonable fee for the operation of a mandatory commercial registrant within its jurisdiction.
(d) Enacting other laws consistent with this chapter.
(a) There is hereby created in the Department of Alcoholic Beverage Control the Division of Medical Cannabis Regulation and Enforcement. The division shall be administered by a person exempt from the civil service who is appointed by the director.
(b) The department shall have the exclusive power, consistent with the provisions of this chapter, to register persons for the cultivation, manufacture, testing, transportation, storage, distribution, and sale of medical cannabis within the state and to collect registration fees in connection with these actions.
The department shall have all power necessary for administration of this chapter, including, but not limited to, the following:
(a) Establishing statewide standards for the commercial cultivation, manufacturing, testing, transportation, storage, distribution, and sale of medical cannabis and medical cannabis products and procedures for the issuance, renewal, suspension, and revocation of registrations of mandatory commercial registrants.
(b) Establishing a scale of application, registration, and renewal fees, to be imposed by the state, for mandatory commercial registrants for the cultivation, manufacturing, testing, transportation, distribution, and sale of medical cannabis and medical cannabis products. The department may charge separate fees for each mandatory commercial registration application for cultivation, manufacturing, transportation, distribution, and sale. The total fees imposed pursuant to this chapter shall be reasonable and based on the actual costs of administering and enforcing this chapter.
(c) The department shall make and prescribe those reasonable rules as may be necessary or proper to carry out the purposes and intent of this chapter and to enable it to exercise the powers and perform the duties conferred upon it by this chapter and in accordance with Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. For the performance of its duties, the department has the powers as set forth in Article 2 (commencing with Section 11180) of Chapter 2 of Part 1 of Division 3 of Title 2 of the Government Code.
(d) Approving or denying mandatory commercial registration applications for cultivation, manufacturing, testing and labeling, transportation, distribution, and sale of medical cannabis pursuant to this chapter.
(e) The department shall have the power, in its discretion, to deny, suspend, revoke, or fine any registration issued pursuant to this chapter if the department determines, for good cause, that the granting or continuance of the registration would be contrary to public welfare or morals or that a person holding or seeking a registration has violated any law prohibiting conduct involving moral turpitude.
(f) Imposing any penalty authorized by this chapter or any rule or regulation adopted pursuant to this chapter.
(g) Taking any reasonable action with respect to a mandatory commercial registration application in accordance with procedures established pursuant to this chapter.
(h) Upon the denial of any application for a registration, the department shall notify the applicant in writing. After service of the notice and within the time prescribed by the department, the applicant may present his or her written petition for a registration to the department. Upon receipt by the department of a petition for a registration in proper form, the petition shall be set for hearing.
(i) (1) For any hearing held pursuant to this chapter, the department may delegate the power to hear and decide to an administrative law judge appointed by the director. Any hearing before an administrative law judge shall be pursuant to the procedures, rules, and limitations prescribed in Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code.
(2) Prior to suspending, revoking, or fining any registration, the department shall file an accusation as provided for in Section 11503 of the Government Code, and the registrant may request a hearing.
(j) Developing any forms, identification certificates, and applications that are necessary or convenient in the reasonable discretion of the department for the administration of this chapter or any of the rules or regulations adopted pursuant to this chapter.
(k) Overseeing the operation of the Medical Cannabis Regulation Fund established pursuant to Section 26028.
(l) Establishing reasonable fees for processing all applications, registrations, notices, or reports required to be submitted to the department. The amount of the fees shall reflect, but shall not exceed, the direct and indirect costs of the department for the administration of this chapter and the rules or regulations adopted pursuant to this chapter.
(m) The department may consult with other state agencies, departments, or public or private entities for the purposes of establishing statewide standards and regulations.
26024.
(a) The department may assist state taxation authorities in the development of uniform policies for the taxation of mandatory commercial registrants.
(b) The department shall assist the Division of Occupational Safety and Health in the Department of Industrial Relations in the development of industry-specific regulations related to commercial medical cannabis activities.
(a) The Medical Cannabis Regulation Fund is hereby established within the State Treasury. Notwithstanding Section 16305.7 of the Government Code, the fund shall include any interest and dividends earned on the money in the fund.
(b) All fees collected pursuant to this chapter shall be deposited into the Medical Cannabis Regulation Fund. Notwithstanding Section 13340 of the Government Code, all moneys within the fund are hereby continuously appropriated, without regard to fiscal year, to the department solely for the purposes of fully funding and administering this chapter, including, but not limited to, the costs incurred by the department for its administrative expenses.
(c) All moneys collected pursuant to this chapter as a result of penalties imposed under this division shall be deposited directly into the General Fund, to be available upon appropriation.
(d) The department may establish and administer a grant program to allocate moneys from the Medical Cannabis Regulation Fund to state and local entities for the purpose of assisting with commercial medical cannabis regulation and the enforcement of this chapter.
(a) The director and the persons employed by the department for the administration and enforcement of this chapter are peace officers in the enforcement of the penal provisions of this chapter, the rules of the department adopted under the provisions of this chapter, and any other penal provisions of law of this state prohibiting or regulating the cultivation, processing, storing, manufacturing, testing, transporting, or selling of medical cannabis, and these persons are authorized, while acting as peace officers, to enforce any penal provisions of law while in the course of their employment.
(b) The director, the persons employed by the department for the administration and enforcement of this chapter, peace officers listed in Section 830.1 of the Penal Code, and those officers listed in Section 830.6 of the Penal Code while acting in the course and scope of their employment as peace officers may, in enforcing the provisions of this chapter, visit and inspect the premises of any mandatory commercial registrant at any time during which the registrant is acting pursuant to the registration.
(c) Peace officers of the Department of the California Highway Patrol, members of the University of California and California State University police departments, and peace officers of the Department of Parks and Recreation, as defined in subdivisions (a), (b), (c), and (f) of Section 830.2 of the Penal Code, may, in enforcing this chapter, visit and inspect the premises of any mandatory commercial registrant located on state property at any time during which the registrant is acting pursuant to the registration.
(a) Information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in records kept by the department for the purposes of administering this chapter are confidential and exempt from the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code) and or not subject to disclosure to any individual or private entity, except as necessary for authorized employees of the State of California to perform official duties pursuant to this chapter:
(b) (1) Nothing in this section precludes the following:
(A) Division employees notifying state or local law enforcement about information submitted to the division that the employee suspects is falsified or fraudulent.
(B) Notifications from the division to state or local law enforcement about apparent criminal violation of this chapter.
(C) Verification of requests by state or local law enforcement to confirm registrants and certificates issued by the division or other state agency.
(D) Provision of information requested pursuant to a court order or subpoena issued by a court.
(2) Information shall not be disclosed beyond what is necessary to achieve the limited goals of a specific investigation or the parameters of a specific court order or subpoena.
Article 3. Mandatory Commercial Registration
(a) On or before January 1, 2015, the department shall promulgate regulations necessary for the implementation and enforcement of this chapter. These regulations shall be reasonable and shall include:
(1) Procedures for the issuance, renewal, suspension, and revocation of mandatory commercial registrations.
(2) Application, registration, and renewal forms and fees consistent with this act.
(3) Time periods, not to exceed 90 days, by which the department shall approve or deny an application for medical cannabis registration.
(4) Qualifications for registrants.
(5) Security requirements, including, but not limited to, procedures for limiting access to facilities and for the screening of employees. The department shall require all registrants to maintain an accurate roster of any employee’s name, date of birth, and relevant personally identifying information, which shall be available for inspection by the department or state or local law enforcement upon demand.
(6) Testing and labeling requirements, including, but not limited to, disclosure of the active cannabinoid profile, constituent elements, active ingredients, and results of testing for contaminants.
(7) Health and safety requirements, including, but not limited to, prohibitions on shipping or distribution of products containing microbiological, bacterial, pathogenic yeast or mold counts, or any adulterant or contaminant, that exceed levels to be determined by the department.
(8) Inspection and tracking requirements, including, but not limited to, an electronic production and inventory tracking system that will allow the department to monitor inventory data at every level of the cultivation, processing, and distribution system through a secure, Internet Web site-based portal.
(9) Storage, packaging, and transportation procedures and protocols.
(10) Advertising restrictions and requirements.
(11) Requirements to ensure conformance with applicable state statutory environmental, agricultural, and food and product safety requirements. The department may consult with the California Environmental Protection Agency to determine whether additional regulations should be issued in order to protect the state’s clean water and environment, including, but not limited to, protections related to land conversion, grading, water diversion and pond development, and agricultural discharges.
(12) Requirements to prevent the diversion of cannabis to nonmedical use, including procedures and protocols for disposal of excess, contaminated, adulterated, or deteriorated products.
(13) Civil penalties for the failure to comply with regulations adopted pursuant to this chapter.
(b) A mandatory commercial registration application or renewal shall not be approved if the department determines any of the following:
(1) The applicant fails to meet the requirements of this chapter or any regulation adopted pursuant to this chapter, including any applicable city or county ordinance or regulation.
(2) The applicant, or any of its officers or directors, is under 21 years of age.
(3) The applicant has knowingly answered a question or request for information falsely on the application form or failed to provide information requested.
(4) The applicant, or any of its officers or directors, has been convicted in the previous five years of a violent felony, as specified in subdivision (c) of Section 667.5 of the Penal Code, a serious felony as specified in subdivision (c) of Section 1192.7 of the Penal Code, a felony offense involving fraud or deceit, or any other felony that, in the department’s estimation, would impair the applicant’s ability to appropriately operate as a mandatory commercial registrant.
(5) The applicant, or any of its officers or directors, is a licensed physician making patient recommendations for medical cannabis.
(6) The applicant, or any of its officers or directors, has been sanctioned by the department, a city, or a county for unregistered commercial medical cannabis activities or has had a mandatory commercial registration revoked in the previous three years.
(7) A sufficient number of mandatory commercial registrants already exists in the state, a city, or a county to provide a sufficient amount of medical cannabis to satisfy patients’ medical use in that jurisdiction.
(c) (1) In order to protect the public safety and provide patients with prompt, safe access to medical cannabis during implementation of this chapter, within 180 days of January 1, 2014, the department shall issue emergency regulations consistent with this chapter that allow a qualified applicant for mandatory commercial registration to apply, be reviewed, and be registered to cultivate, process, manufacture, store, and transport medical cannabis so as to ensure an adequate supply of medical cannabis upon full implementation of this chapter.
(2) The department shall establish appropriate fees as part of its emergency regulations adopted pursuant to this chapter.
For the purpose of regulating the commercial cultivation, manufacturing, testing, transportation, distribution, and sale of medical cannabis, the department, in its reasonable discretion, may establish various classes or types of registration for specific commercial medical cannabis-related activities, as set forth in this chapter.
(a) Each mandatory commercial registration application approved by the department pursuant to this chapter is separate and distinct. An applicant may apply for mandatory commercial registration in more than one class of specified medical cannabis activities.
(b) A mandatory commercial registration application approved by the department pursuant to this chapter shall be valid for a period not to exceed one year from the date of approval unless revoked or suspended pursuant to this chapter or the rules or regulations adopted pursuant to this chapter.
(a) The department shall limit the number of registrations statewide for the cultivation, processing, extraction, packaging, and transportation of medical cannabis to a number no greater than what is necessary to meet statewide need. In determining the appropriate number of registrations, the department may take into account information obtained from sources that include, but need not be limited to, municipalities, patients, and registrants.
(b) The department shall ensure that the number of registrations that it approves does not exceed the ability of the department to enforce the provisions of this chapter, particularly with respect to ensuring patient safety and preventing illegal diversion of cannabis.
(c) In establishing limits pursuant to this section, the department shall consider the following:
(1) The purposes and intent of the Compassionate Use Act of 1996 to ensure an adequate supply of medical cannabis while endeavoring to prevent an oversupply of cannabis that may result in diversion.
(2) The number of applicants for mandatory commercial registrations whose application demonstrates that they will be able to produce consistent products with strict quality controls, in full compliance with this chapter and with all applicable state and local regulations, and the amount of medical cannabis those applicants will be able to provide.
Every mandatory commercial registration is renewable unless the registration has been revoked if the renewal registration is made and the fee for it is paid. All registrations expire at 12 midnight on the last day of the month posted on the registration. All registrations issued shall be renewed as follows:
(a) On or before the first of the month preceding the month posted on the registration, the department shall mail to each registrant at his or her registered premises, or at any other mailing address that the registrant has designated, an application to renew the registration.
(b) The application to renew the registration may be filed before the registration expires upon payment of the annual fee.
(c) For 60 days after the registration expires, the registration may be renewed upon payment of the annual renewal fee plus a penalty fee that shall be equal to 50 percent of the annual fee.
(d) Unless otherwise terminated, or unless renewed pursuant to subdivision (b) or (c), a registration that is in effect on the month posted on the registration continues in effect through 12 midnight of the 60th day following the month posted on the registration, at which time it is automatically canceled.
(e) On or before the 10th day preceding the cancellation of a registration, the department shall mail a notice of cancellation to each registrant that has not either filed an application to renew its registration or notified the department of its intent not to do so. Failure to mail the renewal application in accordance with subdivision (a) or to mail the notice provided in this subdivision shall not continue the right to a registration.
(f) A registration that has been canceled pursuant to subdivision (d) may be reinstated during the 30 days immediately following cancellation upon payment by cashier’s check or money order of the annual renewal fee, plus a penalty fee that shall be equal to 100 percent of the annual fee. A registration that has been canceled pursuant to subdivision (d) and that has not been reinstated within 30 days pursuant to this subdivision is automatically revoked on the 31st day after the registration has been canceled.
(g) A renewal application shall not be deemed filed within the meaning of this section unless the document itself has been actually delivered to, and the required renewal fee has been paid at, any office of the department during office hours, or unless both the document and fee have been filed and remitted pursuant to Section 11003 of the Government Code.
An application for mandatory commercial registration shall include, but shall not be limited to, all of the following:
(a) For all applicants:
(1) The legal name and proposed physical addresses of the mandatory commercial registrant.
(2) The name, address, and date of birth of each principal officer and board member.
(3) Operating and inventory control procedures to ensure security and prevent diversion.
(4) Detailed operating procedures for the proposed facility, which shall include, but not be limited to, provisions for facility and operational security, prevention of diversion, employee screening, storage of medical cannabis, personnel policies, and recordkeeping procedures.
(5) A list of all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on any property that will be used by the applicant.
(6) Evidence of the legal right to occupy and use an established location, or an immunity from prosecution for that occupancy or use pursuant to a local ordinance or ordinances, for the activities to be conducted if the desired registration is granted consistent with the provisions of this chapter and the regulations developed by the department.
(7) Documentation that the applicant will be in compliance with all local ordinances and regulations, including an entity granted immunity under Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013, ballot.
(8) Evidence that officers and owners of the applicant organization are citizens of the United States and residents of the State of California.
(b) In addition to the requirements of subdivision (a), for cultivation and processing applicants, detailed operating procedures for cultivation, extraction and infusion methods, transportation of products, inventory procedures, procedures for quality control, and onsite testing of product for potential contaminants.
Upon receipt of an application for a registration and the applicable fee, the department shall make a thorough investigation to determine whether the applicant and the premises for which a registration is applied qualify for the registration and whether the provisions of this chapter have been complied with, and shall investigate all matters connected therewith which may affect the public welfare and morals. The department shall deny an application for a registration if either the applicant or the premises for which a registration is applied do not qualify for a registration under this chapter. The department further shall deny an application for a registration if issuance of that registration would tend to create a law enforcement problem. The department may place reasonable conditions upon registrations if grounds exist for denial of the registration, and the department finds those grounds may be removed by the imposition of those conditions.
A physician shall not recommend medical cannabis to a patient while the physician is a mandatory commercial registrant, or an officer, director, employee, or financial beneficiary of a mandatory commercial registrant.
(a) The actions of a mandatory commercial registrant or provisional registrant, its employees, and its agents, permitted pursuant to a mandatory commercial registration or provisional registration issued by the department or otherwise permitted by this chapter, that are conducted in accordance to the requirements of this chapter and regulations adopted pursuant to the authority granted by this chapter, are not unlawful and shall not be an offense subject to arrest, prosecution, or other sanction under state or local law, or be subject to a civil fine or be a basis for seizure or forfeiture of assets under state or local law.
(b) The actions of a person who, in good faith and upon appropriate investigation, allows his or her property to be used by a mandatory commercial registrant or provisional registrant, its employees, and its agents, as permitted pursuant to a mandatory commercial registration or provisional registration issued by the department or otherwise permitted by this chapter, are not unlawful and shall not be an offense subject to arrest, prosecution, or other sanction under state or local law, or be subject to a civil fine or be a basis for seizure or forfeiture of assets under state or local law.
(a) A registrant shall not cultivate, process, store, manufacture, test, transport, or sell medical cannabis in the state unless accurate records are kept at the registered premises of the growing, processing, storing, manufacturing, testing, transporting, or selling by the registrant in the state. These records shall include all expenditures incurred by the registrant, provided that a registrant registered to act at more than one premises may keep all records at one of the registered premises. Required records shall be kept for a period of three years from the date of the transaction.
(b) The department may make any examination of the books and records of any registrant and may visit and inspect the premises of any registrant that the department may deem necessary to perform its duties under this chapter.
26052.
(a) This chapter shall not apply to, and shall have no diminishing effect on, the rights and protections granted to a patient or a primary caregiver pursuant to the Compassionate Use Act of 1996.
(b) (1) A patient who cultivates, possesses, stores, manufactures, or transports cannabis exclusively for his or her personal medical use and who does not sell or distribute cannabis is not considered a commercial registrant and is exempt from mandatory commercial registration.
(2) A primary caregiver who cultivates, possesses, stores, manufactures, transports, or provides cannabis exclusively for the personal medical purposes of a specified qualified patient for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code and who does not sell or distribute cannabis except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code is not considered a commercial registrant and is exempt from mandatory commercial registration.
Beginning January 1, 2014, the department shall provide for provisional registrations as follows:
(a) The department shall request that every city or county, provide the department with a list of approved entities providing medical cannabis to qualified patients and caregivers within the city or county’s jurisdiction, the location at which the entity is operating, and the names of the persons who operate the entity. If Unless the jurisdiction represents that the entity has not been operating in compliance with local laws and regulations, or does not have limited immunity under local laws, the department shall issue a provisional registration to the entity until the time that the entity’s application for mandatory commercial registration has been approved or denied under this chapter, but no later than 90 days after the department begins accepting applications for mandatory commercial registration.
(b) The department shall issue a provisional registration to individuals and entities that the department determines were, during the six months prior to January 1, 2014, regularly cultivating or distributing medical cannabis collectively or cooperatively in full compliance with paragraphs A and B of Section IV of the Guidelines for Security and Non-Diversion of Marijuana Grown for Medical Use, issued by the Department of Justice in August 2008, to continue to do so until such time as the registrant’s application for mandatory commercial registration has been approved or denied under this chapter, but no later than 90 days after the department begins accepting applications for mandatory commercial registration. In determining compliance, the department shall consider any complaints or actions made or brought by a city or county against the individual or entity. To qualify, provisional registrants shall be required to disclose to the department the following information in writing on or before January 20, 2014, in order to obtain provisional registration:
(2) The common street address and assessor’s parcel number of the property at which any cultivation activity was or is to be conducted.
(3) For the six months prior to January 1, 2014, the quantity of cannabis cultivated at a location and the quantity expected to be cultivated from January 1, 2014, to June 30, 2014, inclusive. The registrant shall make its records of current activity and activity for the six months prior to January 1, 2014, available to the department upon request.
(c) The department shall charge an application fee of five thousand dollars ($5,000) for each provisional registration.
Entities that are provided immunity under Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013, ballot, shall be considered the equivalent of entities that are registered, permitted, or licensed as a medical marijuana business, dispensary, or other entity involved in providing medical marijuana to patients under a local ordinance and shall be considered in compliance with a local ordinance for the purposes of the implementation of the act adding this section and any regulations promulgated by the department.
26056.
In addition to other regulations adopted by the department pertaining to mandatory commercial registrants and without limiting the authority of a city or a county pursuant to Section 26010 or subdivision (b) of Section 26060, the department shall adopt regulations regarding the minimum standards for the operation of dispensaries that establish all of the following:
(a) Standards for labeling of products, including the name of the mandatory commercial registrant from which the product was obtained, and a requirement that dispensaries provide patients with detailed written information about the contents of the cannabis and medical cannabis products they obtain.
(b) Requirements for inventory control and reporting that require all dispensaries to be able to demonstrate the present location, amounts, and descriptions of all medical cannabis products from the time of delivery to the dispensary until purchase by a qualified patient or primary caregiver.
(c) The maximum number of dispensaries that may operate in a city or county or the unincorporated areas of a county based on population, taking into consideration the distances that patients in rural areas may need to travel in order to reach a dispensary and the availability of public transportation in both rural and urban areas.
(d) Minimum educational and testing requirements for dispensary staff, including background checks, and a requirement that every dispensary maintain dedicated security staff both inside and outside the dispensary.
(e) Maximum hours of operation for every dispensary.
(f) Minimum standards governing signage and advertising for dispensaries.
The department shall make recommendations to the Legislature pertaining to the establishment of an appeals and judicial review process for persons aggrieved by a final decision of the department.
(a) The department shall work in conjunction with law enforcement entities throughout the state for the purpose of implementing and enforcing the rules and regulations regarding commercial medical cannabis and taking appropriate action against businesses and individuals who fail to comply with the law.
(b) Nothing in this chapter shall prevent a city, county, or city and county from enforcing a zoning ordinance or law of general application.
Except for a person identified in Section 26052, a person shall not exercise the privilege or perform any act that a registrant may exercise or perform under the authority of a registration unless the person is acting pursuant to a registration, including a provisional registration, issued pursuant to this chapter.
(a) Commencing January 1, 2015, any product containing cannabis that is distributed, except in the case of a primary caregiver distributing to a qualified patient, or offered for sale shall comply with the testing and labeling requirements established through regulation by the department.
(b) No person shall steal or fraudulently use a mandatory commercial registrant identification certificate or registration or other registrant’s identification card or registration issued by the department to acquire, cultivate, transport, produce, possess for sale, sell, or distribute cannabis.
(c) No person shall counterfeit, tamper with, or fraudulently produce an identification card or registration status.
(d) Any person who violates this section, or Section 26062, is guilty of a misdemeanor and shall be subject to the following penalties:
(1) For the first offense, imprisonment in a county jail for no more than six months or a fine not to exceed one thousand dollars ($1,000), or both.
(2) For a second or subsequent offense, imprisonment in a county jail for no more than one year or a fine not to exceed one thousand dollars ($1,000), or both.
(e) Any person who is charged, prosecuted, or subjected to a civil penalty under this chapter shall not also be charged or prosecuted pursuant to the Health and Safety Code for conduct arising from the same set of facts.
Any person operating an unregistered facility, building, structure, or location where cannabis is being commercially cultivated, manufactured, or possessed for sale in violation of this chapter may be subject to civil penalties of up to twenty-five thousand dollars ($25,000) for each violation, and the department may order the destruction of any cannabis associated with that violation. Any civil fines collected pursuant to this section shall be deposited into the General Fund pursuant to Section 26028.
The director may bring an action to enjoin a violation or the threatened violation of any provision of this chapter, including, but not limited to, a registrant’s failure to correct objectionable conditions following notice or as a result of any rule promulgated pursuant to this chapter. The action shall be brought in the county in which the violation occurred or is threatened to occur. Any proceeding brought pursuant to this chapter shall conform to the requirements of Chapter 3 (commencing with Section 525) of Title 7 of Part 2 of the Code of Civil Procedure.
(a) A state or local law enforcement agency shall immediately notify the department of any arrests made for violations over which the department has jurisdiction which involve a registrant or registered premises. Notice shall be given within 10 days of the arrest. The department shall promptly cause an investigation to be made as to whether grounds exist for suspension or revocation of a registration of the registrant.
(b) The department shall not open or add an entry to a file or initiate an investigation of a registrant or suspend or revoke a registration in either of the following circumstances:
(1) Solely because the registrant or an agent acting on behalf of the registrant has reported to a state or local law enforcement agency that suspected controlled substance violations have taken place on the registered premises.
(2) Solely based on activities constituting violations described in a report made under paragraph (1), unless the violations reported occurred with the actual knowledge and willful consent of the registrant.
Nothing in this chapter shall be construed to limit a law enforcement agency’s ability to investigate unlawful activity in relation to a mandatory commercial registrant.
The department shall create and maintain a searchable database that will allow state and local law enforcement to verify a mandatory commercial registration.
5.Appeals and Judicial Review
There is in the state government, in the Business, Consumer Services, and Housing Agency, a Medical Cannabis Appeals Board. The Medical Cannabis Appeals Board, also referred to as the board in this chapter, shall exercise the powers as are vested in it by this chapter and may adopt such rules pertaining to appeals and other matters within its jurisdiction as may be required. The board and its duly authorized representatives in the performance of its duties under this chapter shall have the powers of a head of a department as set forth in Article 2 (commencing with Section 11180) of Chapter 2 of Part 1 of Division 3 of Title 2 of the Government Code.
(a)Any person aggrieved by a final decision of the department issuing, denying, suspending, revoking, or ordering any penalty assessment against a registration for the cultivation, manufacture, testing, transportation, storage, distribution, sale, purchase, or possession of medical cannabis may appeal to the board, which shall review the decision subject to the limitations that may be imposed by the Legislature.
(b)No decision of the department shall become effective during the period in which an appeal may be filed, and the filing of an appeal shall stay the effect of the decision until such time as a final order is made by the board.
The review by the board of a decision of the department shall be limited to whether:
(a)The department has proceeded without, or in excess of, its jurisdiction.
(b)The department has proceeded in the manner required by law.
(c)The decision is supported by the findings.
(d)The findings are supported by substantial evidence in the light of the whole record.
(e)There is relevant evidence that, in the exercise of reasonable diligence, could not have been produced or which was improperly excluded at the hearing before the department.
(a)The board shall determine the appeal upon the record of the department and upon any briefs that may be filed by the parties. If any party to the appeal requests to appear before the board, the board may fix a time and place for argument. The board shall not receive any evidence other than that contained in the record of the proceedings of the department.
(b)Chapter 4.5 (commencing with Section 11400) of Part 1 of Division 3 of Title 2 of the Government Code does not apply to the determination.
(a)Except as provided in subdivision (b), the board shall enter an order either affirming or reversing the decision of the department.
(b)If the board finds that there is relevant evidence that in the exercise of reasonable diligence could not have been produced or which was improperly excluded at the hearing before the department, the board may enter an order remanding the matter to the department for reconsideration in light of the relevant evidence.
(c)When the board reverses a decision of the department, the board may direct reconsideration in light of its order and may direct the department to take further action as is specifically enjoined upon it by law, but shall not limit or control in any way the discretion vested by law in the department.
Each order of the board on appeal from a decision of the department shall be in writing and shall be filed by delivering copies to the parties personally or in the manner prescribed by Section 1013 of the Code of Civil Procedure. Each order shall become final upon being filed as provided in this section, and there shall be no reconsideration or rehearing by the board.
(a)Any person affected by a final order of the board, including the department, may apply to the Supreme Court or to the court of appeal for the appellate district in which the proceeding arose, for a writ of review of the final order. The application for writ of review shall be made within 30 days after filing of the final order of the board.
(b)No court of this state, except the Supreme Court and the courts of appeal to the extent specified in this article, shall have jurisdiction to review, affirm, reverse, correct, or annul any order, rule, or decision of the department or to suspend, stay, or delay the operation or execution of it, or to restrain, enjoin, or interfere with the department in the performance of its duties, but a writ of mandate shall lie from the Supreme Court or the courts of appeal in any proper case.
(c)No decision of the department which has been appealed to the board and no final order of the board shall become effective during the period in which application may be made for a writ of review, as provided within this section.
(d)The filing of a petition for, or the pendency of, a writ of review shall not of itself stay or suspend the operation of any order, rule, or decision of the department, but the court before which the petition is filed may stay or suspend, in whole or in part, the operation of the order, rule, or decision of the department subject to review, upon the terms and conditions which it by order directs.
The writ of review shall be made returnable at a time and place then or thereafter specified by court order and shall direct the board to certify the whole record of the department in the case to the court within the time specified. No new or additional evidence shall be introduced in the court, but the cause shall be heard on the whole record of the department as certified to by the board.
(a)The review by the court shall not extend further than to determine, based on the whole record of the department as certified by the board, whether:
(1)The department has proceeded without or in excess of its jurisdiction.
(2)The department has proceeded in the manner required by law.
(3)The decision of the department is supported by the findings.
(4)The findings in the department’s decision are supported by substantial evidence in the light of the whole record.
(5)There is relevant evidence which, in the exercise of reasonable diligence, could not have been produced or which was improperly excluded at the hearing before the department.
(b)Nothing in this article shall permit the court to hold a trial de novo, to take evidence, or to exercise its independent judgment on the evidence.
The findings and conclusions of the department on questions of fact are conclusive and final and are not subject to review. The questions of fact shall include ultimate facts and the findings and conclusions of the department. The board, the department, and each party to the action or proceeding before the board shall have the right to appear in the review proceeding. Following the hearing, the court shall enter judgment either affirming or reversing the decision of the department or the court may remand the case for further proceedings before or reconsideration by the department.
The provisions of the Code of Civil Procedure relating to writs of review shall, insofar as applicable, apply to proceedings in the courts as provided by this article. A copy of every pleading filed pursuant to this article shall be served on the board, the department, and on each party who entered an appearance before the board.
Whenever any matter is pending before the board or a court of record involving a dispute between the department and a registrant, and the parties to the dispute agree upon a settlement or adjustment of it, the tribunal shall, upon the stipulation by the parties that an agreement has been reached, remand the matter to the department.
Article 5. Transportation of Medical Cannabis
To claim the protections of this chapter and to maintain a valid mandatory commercial registration, a registrant shall ship medical cannabis products only in response to a request for a specific quantity and variety from a registered dispensary or mandatory commercial registrant.
(a) Prior to transporting any medical cannabis product, a mandatory commercial registrant shall do the following:
(1) Complete a shipping manifest using a form prescribed by the department.
(2) Securely transmit a copy of the manifest to the mandatory commercial registrant that will receive the medical cannabis product and to the department prior to transport.
(b) The mandatory commercial registrant shipping and the registrant receiving shall maintain each shipping manifest and make it available to the department upon request.
(a) Transported medical cannabis products shall:
(1) Be transported only in a locked, safe and secure storage compartment that is securely affixed to the interior of the transporting vehicle.
(2) Not be visible from outside the vehicle.
(b) Any vehicle transporting medical cannabis products shall travel directly from the facilities of mandatory commercial registrant to the registrant authorized to receive the shipment.
(a) A mandatory commercial registrant shall staff all transport vehicles with a minimum of two employees. At least one delivery team member shall remain with the vehicle at all times that the vehicle contains medical cannabis.
(b) Each delivery team member shall have access to a secure form of communication by which each member can communicate with personnel at the mandatory commercial registrant facility at all times that the vehicle contains medical cannabis.
(c) Each delivery team member shall possess documentation of mandatory commercial registration and a government-issued identification card at all times when transporting or delivering medical cannabis and shall produce it to any representative of the department or law enforcement official upon request.
Section 11362.7 of the Health and Safety Code is amended to read:
(a) “Attending physician” means an individual who possesses a license in good standing to practice medicine or osteopathy issued by the Medical Board of California or the Osteopathic Medical Board of California and who has taken responsibility for an aspect of the medical care, treatment, diagnosis, counseling, or referral of a patient and who has performed an appropriate prior examination, found that the patient has a medical indication, and recommends marijuana for medical purposes to treat a serious medical condition.
(g) “Identification card” means a document issued by the State Department of Public Health that document identifies a person authorized to engage in the medical use of marijuana and the person’s designated primary caregiver, if any.
(a) Qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards, who associate within the State of California in order collectively or cooperatively to cultivate marijuana for medical purposes, shall not solely on the basis of that fact be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570.
(b) This section shall remain in effect only until 90 days after the Department of Alcoholic Beverage Control posts a notice on its Internet Web site that it began accepting applications for mandatory commercial registration pursuant to Article 3 (commencing with Section 26040) of Chapter 18 of Division 9 of the Business and Professions Code, and as of that date is repealed.
The Legislature finds and declares that Section 3 of this act imposes a limitation on the public’s right of access to documents in the possession of a public agency within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following finding to demonstrate the interest protected by this limitation and the need for protecting that interest:
It is necessary to maintain the confidentiality of patient and physician information provided to the Division of Medical Cannabis Regulation and Enforcement in order to protect the private medical information of patients who use medical cannabis and to preserve the essential confidentiality of the physician and patient relationship.